Early Look: New Methods To Enhance Cholesterol Efflux

Although clinical trials of HDL-boosting CETP inhibitors have so far failed to produce positive results, many other avenues of HDL-related research remain active.  A glimpse at the very early phases of two intriguing lines of research in this area was offered on Monday at the AHA. Apo A-1 is thought to be the key HDL…

Click here to continue reading…